Status:
COMPLETED
Pharmacokinetics of Aminocaproic Acid in Scoliosis Surgery
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborating Sponsors:
Children's Anesthesiology Associates, Ltd.
Conditions:
Scoliosis
Eligibility:
All Genders
8-18 years
Brief Summary
This study will evaluate the pharmacokinetics of antifibrinolytic drug epsilon-aminocaproic acid (EACA) in children undergoing Posterior spinal fusion surgery (PSF) at The Children's Hospital of Phila...
Detailed Description
Posterior spinal fusion surgery (PSF) can be associated with significant blood loss, and perioperative transfusion is common. Various strategies have been employed to decrease intraoperative blood los...
Eligibility Criteria
Inclusion
- 1)Males or females age 8 to 18 years 2)Subjects undergoing posterior spinal fusion surgery 3)Subjects in whom aminocaproic acid administration is planned by the anesthesiology team 4)Parental/guardian permission (written informed consent) and when appropriate, child assent.
- \-
Exclusion
- Wards of the State are not eligible
- Subjects with a history of abnormal renal function -
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01408823
Start Date
July 1 2011
End Date
October 1 2011
Last Update
August 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104